Literature DB >> 29018734

Optimizing surgical treatments in rhegmatogenous retinal detachment.

Chi-Chun Lai1.   

Abstract

Entities:  

Year:  2016        PMID: 29018734      PMCID: PMC5525621          DOI: 10.1016/j.tjo.2016.10.001

Source DB:  PubMed          Journal:  Taiwan J Ophthalmol        ISSN: 2211-5056


× No keyword cloud information.
Rhegmatogenous retinal detachment (RRD) is an important cause of visual impairment and one of the most common ocular emergencies threatening vision. Timely surgical intervention is crucial to prevent permanent visual loss. The fundamental principles used in the surgical management of RD are the identification and subsequent closing of all retinal breaks, and relieving vitreous traction on the retina. Most of the early postoperative redetachment was due to an inability to achieve one or both of these objectives. Although the cause of a late failure in RD is difficult to identify, the most commonly reported one is proliferative vitreoretinopathy.1 It is therefore important to use the most appropriate surgical approach for patients with RRD, minimizing the risk of visual loss due to these surgical failures. In the review article, “Primary retinal detachment: a review of the development of techniques for repair in the past 80 years”, Ingrid Kreissig presented a concise overview of the evolution of surgical techniques used to reattach primary RD. Furthermore, current techniques were also analyzed with regard to their effect on morbidity, reoperation, and long-term visual function. This article provides an excellent review related to historical perspectives on the management of RD. Kreissig reviewed the first conceptual progress in the treatment of RD, postulated by Jules Gonin 90 years ago, that a retinal break is the main cause of RD and applied ignipuncture around the break hopefully to seal the break and reattach the retina. In 2015, Albert et al2 wrote an article on Jules Gonin in Ophthalmology. They described how he could serve as a role model for future scientists taking on audacious goals. He is admired not only for his high level of intelligence, but also for his creativity, networking skills, ability to take risks, and capability to adapt. Kreissig also presented the paper at the Fourth Annual Meeting of the Taiwan Retinal Society. She mentioned that the aim of fixing RRD is to find and close breaks sufficiently from both the extraocular approach with scleral buckling and intraocular approach with pneumatic retinopexy or vitrectomy. This lecture offered a new perspective and practical recommendations regarding the optimal management of primary RRD. Recently, surgical approaches for RRD have evolved rapidly. Endoscopic vit-rectomy is complementary to conventional viewing systems and has a role in complex anterior RD, particularly in diseases in chil-dren.3 The use of chandelier endoillumination improves visualization in challenging cases and it allows the technique of bimanual surgery.4 Furthermore, chandelier light systems have enabled surgeons to perform peripheral vitreous shaving without the need of an assistant. By combining traditional scleral buckling with contemporary vitreoretinal visualization techniques, chandelier-assisted scleral buckling is safe and has some advantages over traditional buckling techniques to treat primary RRD. An important advantage of using intraocular illumination and wide-angle viewing system is in its educational value.5 It is more efficient for the trainee to visualize and understand the principles of the scleral buckling procedure by such approach. In the same way, intraoperative optical coherence tomography (OCT) might have a huge impact on our clinical practice in the operating room. Although the widespread clinical use of intrao-perative OCT has yet to be seen, current research suggests that intraoperative OCT will reveal new information regarding the decision-making of surgical management.6 Surgery remains the mainstay of treatment for RRD. With many tools at hand, it is important for surgeons to select the most appropriate treatment options for their patients. In addition to clinical outcome, improving the quality of life is another main benefit of new innovations in the field of surgical retina. Minimally invasive surgery, better viewing system, and advanced imaging tools are reducing pain and allowing patients to spend less time in recovery. We should evaluate surgical interventions from multiple perspectives and continue to find ways to improve clinical practice with updated medical technologies. As more procedures are verified and new technologies are invented and applied in the human eyes, ophthalmologists will be able to make surgery safer and more efficient.
  6 in total

1.  Twin lights: a new chandelier illumination for bimanual surgery.

Authors:  Claus Eckardt
Journal:  Retina       Date:  2003-12       Impact factor: 4.256

Review 2.  Simple retinal detachments: identifying the at-risk case.

Authors:  R H Y Asaria; Z J Gregor
Journal:  Eye (Lond)       Date:  2002-07       Impact factor: 3.775

3.  Why Jules Gonin Achieved His "Audacious Goal Initiative"—and Why He Is a Model for the Present Day.

Authors:  Daniel M Albert; Balder P Gloor; Alice R McPherson
Journal:  Ophthalmology       Date:  2015-10       Impact factor: 12.079

Review 4.  Endoscopic vitrectomy.

Authors:  S Chien Wong; Thomas C Lee; Jeffrey S Heier; Allen C Ho
Journal:  Curr Opin Ophthalmol       Date:  2014-05       Impact factor: 3.761

5.  Novel microarchitectural dynamics in rhegmatogenous retinal detachments identified with intraoperative optical coherence tomography.

Authors:  Justis P Ehlers; Matthew P Ohr; Peter K Kaiser; Sunil K Srivastava
Journal:  Retina       Date:  2013 Jul-Aug       Impact factor: 4.256

6.  SCLERAL BUCKLING WITH WIDE-ANGLED ENDOILLUMINATION AS A SURGICAL EDUCATIONAL TOOL.

Authors:  Raja Narayanan; Mudit Tyagi; Abdullah Hussein; Jay Chhablani; Rajendra S Apte
Journal:  Retina       Date:  2016-04       Impact factor: 4.256

  6 in total
  1 in total

1.  Pneumoretinopexy versus scleral buckling in retinal detachments with superior breaks: A comparative analysis of outcome and cost.

Authors:  Arshi Singh; Umesh Chandra Behera
Journal:  Indian J Ophthalmol       Date:  2021-02       Impact factor: 1.848

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.